Find out who in your province has access to public coverage for HPV vaccination.
For complete and up-to-date information, please consult the link provided for each province & territory. GARDASIL®9 is indicated in individuals 9 to 45 years of age.
Select your province or territory
ALBERTA
Alberta
Last updated March 2026.
School based dosing schedule for the HPV vaccine (GARDASIL®9):
- Eligible grade 6 students
Free eligibility criteria:
- If you did not get the HPV-9 vaccine in grade 6, you can still get it for free up to and including age 26 years
-
People 9-45 years of age may be able to get this vaccine for free if they:
- have had or are going to have an organ transplant
- have had a stem cell transplant or CAR T-cell therapy (a type of cancer treatment)
For complete & up-to-date information, please consult the Alberta Health Services website.
BRITISH COLUMBIA
British Columbia
Last updated April 2026.
School based dosing schedule for the HPV vaccine (GARDASIL®9):
- Eligible grade 6 students
Free eligibility criteria:
- Individuals 9-26 years of age
- People 27-45 years of age who self-identify as gay, bisexual, and other men who have sex with men (GBMSM), —including those who are not yet sexually active and/or questioning their sexual orientation—cisgender males, Two-spirit, transgender, and non-binary people
- People 27-45 years of age who are HIV positive
- People treated for abnormal cervical changes following colposcopy (on or after July 31, 2025)
For complete & up-to-date information, please consult the HealthLink BC website.
MANITOBA
Manitoba
Last updated March 2026.
School based dosing schedule for the HPV vaccine (GARDASIL®9):
- Eligible grade 6 students
Free eligibility criteria:
- Healthy females born on or after January 1, 1997 and healthy males born on or after January 1, 2002, routinely provided as part of the grade 6 school-based immunization program
- Individuals with at least one high-risk criteria
For complete information about the criteria, refer to Manitoba’s Immunization Program
For complete & up-to-date information, please consult the Manitoba Government website.
NEW BRUNSWICK
New Brunswick
Last updated March 2026.
School based dosing schedule for the HPV vaccine (GARDASIL®9):
- Eligible grade 7 students
Free eligibility criteria:
- All females 9-26 years of age who did not receive the vaccine in school
- All males 9-26 years of age born on or after 2005 who did not receive the vaccine in school
-
Certain adults up to age 45, who may be at increased risk of HPV, including:
- individuals who self-identify as gay, bisexual, and other men who have sex with men (GBMSM)
- immunocompromised individuals, including those with HIV
For complete & up-to-date information, please consult the Government of New Brunswick website.
NEWFOUNDLAND AND LABRADOR
Newfoundland and Labrador
Last updated March 2026.
School based dosing schedule for the HPV vaccine (GARDASIL®9):
- The HPV-9 vaccine is offered to all girls and boys in grade 6
Free eligibility criteria:
- Individuals who missed the vaccine series in grade 6 (females since 2007 and males since 2017) can get it for free through Public Health Nursing
For complete & up-to-date information, please consult the Government of Newfoundland and Labrador website.
NORTHWEST TERRITORIES
Northwest Territories
Last updated March 2026.
School based dosing schedule for the HPV vaccine (GARDASIL®9):
- Eligible grade 4, 5 or 6 students
Free eligibility criteria:
- Individuals 9-26 years of age
For complete & up-to-date information, please consult the Government of Northwest Territories website.
NOVA SCOTIA
Nova Scotia
Last updated March 2026.
School based dosing schedule for the HPV vaccine (GARDASIL®9):
- Eligible grade 7 students
Free eligibility criteria:
- Grade 7 students
- Youth who have missed or refused HPV vaccine as part of the school-based program less than 19 years of age
- Two-spirit, men who have sex with men (MSM), and transgender people (for those up to and including 45 years of age)
- Pre-exposure immunization for those with HIV (for those up to and including 45 years of age)
For complete & up-to-date information, please consult the Nova Scotia Health website.
NUNAVUT
Nunavut
Last updated March 2026.
School based dosing schedule for the HPV vaccine (GARDASIL®9):
- Eligible grade 6 students
Free eligibility criteria:
- Individuals 9-26 years of age
- Other groups may be approved for vaccine coverage on a case-by-case basis based on risk factor and clinical needs
For complete & up-to-date information, please consult the Government of Nunavut website.
ONTARIO
Ontario
Last updated March 2026.
School based dosing schedule for the HPV vaccine (GARDASIL®9):
- Eligible students in grades 7-12
Free eligibility criteria:
- Individuals who did not receive the HPV vaccine in school can get it for free until the end of grade 12
- Gay or bisexual males up to 26 years of age
For complete & up-to-date information, please consult the Government of Ontario website.
PRINCE EDWARD ISLAND
Prince Edward Island
Last updated April 2026.
School based dosing schedule for the HPV vaccine (GARDASIL®9):
- Eligible grade 6 students
Free eligibility criteria:
- Grade 6 students
- Adults 18-26 years of age who did not receive the vaccine in childhood
-
Adults greater than 27 years of age with the following risk factors:
- People having unprotected sex with multiple partners (male and female) or with a partner who has multiple partners
- People with abnormal PAP test results
- People with HIV
- Men who have sex with men (MSM)
- Adults who self-identify as requiring the HPV vaccine.
For complete & up-to-date information, please consult the Prince Edward Island Recommended Adult Vaccines document and the Prince Edward Island Childhood Immunizations website.
QUEBEC
Quebec
Last updated March 2026.
School based dosing schedule for the HPV vaccine (GARDASIL®9):
- Eligible grade 4 students
Free eligibility criteria:
- Individuals 9-20 years of age
- People 21-45 years of age
- With a weakened immune system
- Who are infected with the human immunodeficiency virus (HIV)
- Men up to 26 years of age who have or plan to have sex with men (MSM)
For complete & up-to-date information, please consult the Gouvernement du Québec website.
SASKATCHEWAN
Saskatchewan
Last updated March 2026.
School based dosing schedule for the HPV vaccine (GARDASIL®9):
- Eligible grade 6 students
Free eligibility criteria:
- Adolescents and adults up to 26 years of age
- Select immune compromised individuals 9-26 years of age
For complete & up-to-date information, please consult the Saskatchewan Health Authority website.
YUKON
Yukon
Last updated March 2026.
School based dosing schedule for the HPV vaccine (GARDASIL®9):
- Eligible grade 6 students
Free eligibility criteria:
- Individuals 9-26 years of age
- HIV positive individuals (9-45 years of age)
For complete & up-to-date information, please consult the Yukon Health and Services website.
Safety Information
GARDASIL®9 is a vaccine indicated for individuals 9 through 45 years of age for the prevention of infection caused by the human papillomavirus (HPV) types 6, 11, 16, 18, 31, 33, 45, 52 and 58 and the following diseases associated with the HPV types included in the vaccine: certain head and neck cancers, such as throat and back of mouth cancers, caused by HPV types 16, 18, 31, 33, 45, 52, and 58. GARDASIL®9 has been approved with conditions. This means it has passed Health Canada’s review and can be bought and sold in Canada, but the manufacturer has agreed to complete more studies to make sure the vaccine works the way it should. For more information, talk to your healthcare professional.
GARDASIL®9 is also indicated for individuals 9 through 45 years of age for the prevention of infection caused by the human papillomavirus (HPV) types 6, 11, 16, 18, 31, 33, 45, 52 and 58 and the following diseases associated with the HPV types included in the vaccine: cervical, vulvar, vaginal and anal cancer caused by HPV types 16, 18, 31, 33, 45, 52, and 58; genital warts (condyloma acuminata) caused by HPV types 6 and 11; abnormal and precancerous cervical lesions (changes in cells of the cervix that have a risk of turning into cancer) as found in a Pap test caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58; abnormal and precancerous vaginal, vulvar (outside of the female genital area) and anal lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58.
GARDASIL®9 does not protect the person getting the vaccine from a disease that is caused by other types of HPV, other viruses, or bacteria, and from HPV types that he/she may already have; but most people do not have all types contained in the vaccine. GARDASIL®9 does not treat HPV infection. GARDASIL®9 may not fully protect each person who gets it. GARDASIL®9 does not remove the need for screening for cervical, vulvar, vaginal, anal, and certain head and neck cancers, such as throat and back of mouth cancers; women should still get routine cervical cancer screening. You should not get GARDASIL®9 during pregnancy. If you plan to get pregnant or get pregnant, you should wait until you are no longer pregnant to complete your vaccine series. In more than 1,000 pregnancies, women who were pregnant or became pregnant after getting GARDASIL®9 did not have a higher chance for miscarriages or babies with birth defects. Pregnant women exposed to GARDASIL®9 are encouraged to report their exposure or suspected adverse reactions by contacting Merck Canada Inc., at 1-800-567-2594. It is not known whether GARDASIL®9 is excreted in human milk. If you are breast-feeding, talk to your doctor or healthcare professional to see if you should be vaccinated with GARDASIL®9. Tell the doctor or healthcare professional if you or your child (the person getting GARDASIL®9), is pregnant or is planning to get pregnant. GARDASIL®9 may cause some side effects and allergic reactions. The most common side effects seen are pain, swelling, redness, itching, bruising, bleeding, a lump where the shot is given, headache, fever, nausea, dizziness, tiredness, diarrhea, abdominal pain, and sore throat. Fainting can happen after getting an HPV vaccine. Signs of an allergic reaction may include difficulty breathing, wheezing (bronchospasm), hives and rash. This is not a complete list of side effects; for any unexpected effects while taking GARDASIL®9, contact your healthcare professional. Contact your doctor or healthcare professional to determine if GARDASIL®9 is an appropriate option for you.
Information about GARDASIL®9 is provided in the Product Monograph and Consumer Information, available here.
HPV=human papillomavirus.
